Supernus Pharmaceuticals Stock Target Price and Analyst Consensus

SUPN Stock  USD 31.15  0.73  2.40%   
The current analyst and expert consensus on Supernus Pharmaceuticals is Strong Buy, with 2 strong buy opinions. The current projected Supernus Pharmaceuticals target price consensus is 42.25 with 3 analyst opinions. The most common way Supernus Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Supernus Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Supernus Pharmaceuticals. We encourage you to use your own analysis of Supernus Pharmaceuticals to validate this buy or sell advice. Supernus Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Supernus Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Supernus Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.
Lowest Forecast
38.45
Highest Forecast
46.9
Target Price
42.25
At this time, Supernus Pharmaceuticals' Pretax Profit Margin is very stable compared to the past year. As of the 8th of May 2024, Operating Profit Margin is likely to grow to 0.02, while Gross Profit is likely to drop about 232.3 M. At this time, Supernus Pharmaceuticals' Non Current Assets Total are very stable compared to the past year. As of the 8th of May 2024, Non Currrent Assets Other is likely to grow to about 8.9 M, while Common Stock Shares Outstanding is likely to drop about 42.6 M.
  
It's important to approach Supernus Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Supernus Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Supernus target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Supernus Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   3  Strong Buy
Most Supernus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Supernus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Supernus Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Supernus Pharmaceuticals Target Price Projection

Supernus Pharmaceuticals' current and average target prices are 31.15 and 42.25, respectively. The current price of Supernus Pharmaceuticals is the price at which Supernus Pharmaceuticals is currently trading. On the other hand, Supernus Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Supernus Pharmaceuticals Market Quote on 8th of May 2024

Low Price30.41Odds
High Price31.31Odds

31.15

Target Price

Analyst Consensus On Supernus Pharmaceuticals Target Price

Low Estimate38.45Odds
High Estimate46.9Odds

42.25

Historical Lowest Forecast  38.45 Target Price  42.25 Highest Forecast  46.9
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Supernus Pharmaceuticals and the information provided on this page.

Supernus Pharmaceuticals Analyst Ratings

Supernus Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Supernus Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Supernus Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Supernus Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Supernus Pharmaceuticals price targets

Supernus Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Supernus Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Supernus Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Supernus Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Supernus Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Supernus Pharmaceuticals is a key component of Supernus Pharmaceuticals valuation and have some predictive power on the future returns of a Supernus Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Supernus Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
28.6831.2133.74
Details
Intrinsic
Valuation
LowRealHigh
28.0436.7039.24
Details
Naive
Forecast
LowNextHigh
29.9132.4434.97
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.290.380.48
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Supernus Pharmaceuticals. Your research has to be compared to or analyzed against Supernus Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Supernus Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Supernus Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
FinTech Idea
FinTech
Invested over 40 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
When determining whether Supernus Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Supernus Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Supernus Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Supernus Pharmaceuticals Stock:
Check out Macroaxis Advice on Supernus Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Supernus Stock analysis

When running Supernus Pharmaceuticals' price analysis, check to measure Supernus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Supernus Pharmaceuticals is operating at the current time. Most of Supernus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Supernus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Supernus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Supernus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
The data published in Supernus Pharmaceuticals' official financial statements usually reflect Supernus Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Supernus Pharmaceuticals. For example, before you start analyzing numbers published by Supernus accountants, it's critical to develop an understanding of what Supernus Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Supernus Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Supernus Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Supernus Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Supernus Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Supernus Pharmaceuticals' management manipulating its earnings.